Patents for C12N 9 - Enzymes, e.g. ligases (6.); Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating, or purifying enzymes (141,535) |
---|
12/29/2004 | CN1182246C Mutant ilvH gene and process for producing L-valine |
12/29/2004 | CN1182243C Technique method for preparing nitrile hydratase by using glucose-CO2+ coupling adding ferment |
12/29/2004 | CN1182240C Barm expressing system of plasminogen and purifying process |
12/29/2004 | CA2570502A1 Castanea sativa mill. genes codifying for allene oxide cyclase, cystatin, beta-1,3-glucanase and thaumatin-like protein and their use |
12/29/2004 | CA2533618A1 Methods for diagnosing, monitoring, staging and treating heart failure |
12/29/2004 | CA2530641A1 Directed selective solid-phase culturing of stable microbial mixed populations for the continuous preparation of defined enzyme and metabolite mixture and bioreactor |
12/29/2004 | CA2530043A1 Modulation of coffee flavour precursor levels in green coffee grains |
12/29/2004 | CA2529838A1 Isoforms of eif-5a: senescence-induced eif5a; wounding-induced eif-5a; growth eif-5a; and dhs |
12/29/2004 | CA2529659A1 Engineered proteolytic enzyme with altered specificity determining regions |
12/29/2004 | CA2529589A1 New biological entities and the pharmaceutical or diagnostic use thereof |
12/29/2004 | CA2529565A1 Modified bordetella adenylate cyclase comprising or lacking cd11b/cd18 interaction domain and uses thereof |
12/29/2004 | CA2529105A1 Odor control compositions and methods |
12/28/2004 | US6835867 For genetic mapping; in vitro stem cell cultures |
12/28/2004 | US6835821 Useful mutations of bacterial alkaline protease |
12/28/2004 | US6835817 Monoclonal antibody which is specific for activated coagulation factor VII, and its use |
12/28/2004 | US6835569 Amino polyol oxidase amine polynucleotides and related polypeptides and methods of use |
12/28/2004 | US6835565 Alzheimer's disease secretase |
12/28/2004 | US6835564 Human endothelin converting enzyme-like proteins and polynucleotides encoding the same |
12/28/2004 | US6835562 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof |
12/28/2004 | US6835561 Composition of reverse transcriptases and mutants thereof |
12/28/2004 | US6835555 Interleukin-1 β converting enzyme like apoptosis protease-3 and 4 |
12/28/2004 | US6835550 Mutant proteins having lower allergenic response in humans and methods for constructing, identifying and producing such proteins |
12/28/2004 | US6835370 Diagnosis and treatment of malignant neoplasms |
12/28/2004 | CA2126072C Tri-substituted phenyl derivatives and processes for their preparation |
12/23/2004 | WO2004111257A1 Method for the microbiological isomerisation of alpha-hydroxy carboxylic acids |
12/23/2004 | WO2004111245A2 Gdc-2 genes conferring herbicide resistance |
12/23/2004 | WO2004111242A1 FACTOR VII OR VIIa GLA DOMAIN VARIANTS |
12/23/2004 | WO2004111241A1 Penicillin acylase |
12/23/2004 | WO2004111238A1 Transcription regulatory sequence |
12/23/2004 | WO2004111227A2 Screening process for hydantoin racemases |
12/23/2004 | WO2004111226A1 Urokinase plasminogen activator derived octapeptide in the treatment of multiple sclerosis |
12/23/2004 | WO2004111225A1 Novel modified corin molecules having substitute activation sequences and uses thereof |
12/23/2004 | WO2004111224A1 Improved proteases and methods for producing them |
12/23/2004 | WO2004111223A1 Proteases |
12/23/2004 | WO2004111222A1 Proteases |
12/23/2004 | WO2004111221A1 Proteases |
12/23/2004 | WO2004111220A1 Proteases |
12/23/2004 | WO2004111219A1 Improved proteases and methods for producing them |
12/23/2004 | WO2004111218A2 Method for producing glucoamylases and their uses |
12/23/2004 | WO2004111217A2 Variant pseudomonas polypeptides having a non-maltogenic exoamylase activity and their use in preparing food products |
12/23/2004 | WO2004111216A2 Phospholipase variants |
12/23/2004 | WO2004111215A1 Novel phosphorylated sequences of the phosphatase cdc25b, antibodies for said sequences and use thereof |
12/23/2004 | WO2004111214A1 Feedback-resistant mevalonate kinases |
12/23/2004 | WO2004111198A2 Modified human acid sphingomyelinase having increased activity, and methods for making the same |
12/23/2004 | WO2004111196A2 Mutants of core 2 b-1,6-n-acetylglycosaminyltransferase |
12/23/2004 | WO2004111083A2 Oxidoreductase from pichia capsulata |
12/23/2004 | WO2004111079A1 Viral polymerase and modulation thereof |
12/23/2004 | WO2004111075A2 Alternative reading frame polypeptides for treatment |
12/23/2004 | WO2004111028A1 Cyclic onium compounds and glucosidase inhibitors |
12/23/2004 | WO2004110478A1 Inhibitors of cell migration |
12/23/2004 | WO2004110477A1 Inhibitors of the leukocyte prommp-9/beta(2) integrin complex |
12/23/2004 | WO2004099403A8 A method of increasing the total or soluble carbohydrate content or sweetness of an endogenous carbohydrate by catalysing the conversion of an endogenous sugar to an alien sugar. |
12/23/2004 | WO2004090140A3 Methods and means for increasing the tolerance of plants to stress conditions |
12/23/2004 | WO2004089066A9 Manipulation of organic acid biosynthesis and secretion |
12/23/2004 | WO2004081185B1 Methods to enhance the activity of lignocellulose-degrading enzymes |
12/23/2004 | WO2004078914A3 A fluorinase enzyme and use thereof in fluorination synthesis |
12/23/2004 | WO2004055169A3 Cytochrome c acetylation |
12/23/2004 | WO2004053132A8 A salt tolerant l-myo-inositol 1 phosphate synthase and the process of obtaining the same |
12/23/2004 | WO2004042043A3 Crystal structures of bacterial ribulose-phosphate 3-epimerases |
12/23/2004 | WO2003052075A3 Enzymes |
12/23/2004 | US20040261146 Genes coding for flavone synthases |
12/23/2004 | US20040261137 In which genome encodes human glycogen synthase kinase-3 polypeptide via regulatory sequences; for screening potential agents for the treatment of diabetes and obesity; kits |
12/23/2004 | US20040260019 Zero length cross-linking of proteins and related compounds |
12/23/2004 | US20040259839 Foods, printing dyes, oil well drilling fluids, ceramic glaze, drugs |
12/23/2004 | US20040259833 DNA methyl transferase inhibitors |
12/23/2004 | US20040259829 Carboxylesterase; antitumor agents; drug screening; bioassay |
12/23/2004 | US20040259789 Stimulant gene expression of peptide |
12/23/2004 | US20040259774 Nucleotide sequences; binding to antibodies |
12/23/2004 | US20040259257 Nucleic acid having promoter activity and transformed plant containing the same |
12/23/2004 | US20040259230 Method for producing gamma-glutamylcysteine |
12/23/2004 | US20040259222 Novel group of $g(a)-amylases and a method for identification and production of novel $g(a)-amylases |
12/23/2004 | US20040259221 separation of DNA binding nuclear proteins from a cellular sample before proteomic analysis using a volatile buffer such as ammonium bicarbonate such that no dialysis step is needed between extraction and separation steps |
12/23/2004 | US20040259220 CLK protein kinases and related products and methods |
12/23/2004 | US20040259219 Enhancement of enzyme activity by selective purification |
12/23/2004 | US20040259212 Process for producing purine nucleotides |
12/23/2004 | US20040259210 Which encode bacteriophage signal peptides; for secretion of antibodies and/or fragment antigen binding fragments; cassettes; host cells |
12/23/2004 | US20040259208 Such as mounse transthyretin (mTTR) promoter (antibody); recombinant lentiviruses and transfer vectors for transgene delivery and gene therapy; blood coagulation factor IX; antihemopohilic factor |
12/23/2004 | US20040259207 Polynucleotide and polypeptide sequences of canine cathepsin S |
12/23/2004 | US20040259206 Polynucleotide and polypeptide sequences of monkey cathepsin S |
12/23/2004 | US20040259203 Prokaryotic glycosyltransferases, sialyltransferases, galactosyltransferases, and other enzymes involved with production of lipooligosaccharides; expression cassettes; host cells |
12/23/2004 | US20040259200 Mutated lactococcus strain |
12/23/2004 | US20040259199 32544, Novel human phospholipase C and uses thereof |
12/23/2004 | US20040259198 Methionine adenosyltransferase II (MAT II); hybridoma cell lines; transgenic animals; assay kits |
12/23/2004 | US20040259197 Transforming methylotrophic yeast strain with vector (plasmid, episome) containing pre-protein and signal peptide, cultivating in growth medium comprising nutrients and methanol, then purifying expressed protein; yeast artificial chromosomes; kits |
12/23/2004 | US20040259193 using a polypeptide having JAB subunit or the JAM domain that confers isopeptidase activity to deconjugate a modifier protein from a target protein; e.g. de-ubiquitination; use in drug screening |
12/23/2004 | US20040259192 into two fragments, using the human matrix metalloproteinase MMP-3; administering 3-(3-mercaptopropyl)-1-methyl-(1H,3H)quinazoline-2,4-dione and/or 3-(2'-mercaptoethylamino)-2H-1,2,4-benzothiadiazine-1,1-dioxide to treat tumors or diabetic retinopathy; also wound healing, cardiac infarction treatment |
12/23/2004 | US20040259191 having higher activity on penicillin G; use to produce phenylacetyl-7-aminodeacetoxycephalosporanic acid (7-ADCA) |
12/23/2004 | US20040259166 Methods for designing inhibitors of serine/threonine kinases and tyrosine kinases |
12/23/2004 | US20040259163 Antibodies to mammalian adhesion protease peptides |
12/23/2004 | US20040259147 Gene causative of rothmund-thomson syndrome and gene product |
12/23/2004 | US20040259143 used to screen for agonists and antagonists that can either stimulate or inhibit type V adenylyl cyclase activity |
12/23/2004 | US20040259142 Products and methods |
12/23/2004 | US20040259140 Beta 1,3-galactosyltransferases from C. jejuni |
12/23/2004 | US20040259137 Alpha 1-6 fucosyltransferase |
12/23/2004 | US20040259135 Biosynthetic labeling and separation of RNA |
12/23/2004 | US20040259134 nucleic acid of given sequence encoding glycerol kinase (GK) gene with a novel mutant allele |
12/23/2004 | US20040259126 MN gene and protein |
12/23/2004 | US20040259123 isolated from Aeropyrum pernix, can stand heat treatment at 100 degrees C. and not lose its activity; host cells, nucleotide sequences, and vectors |
12/23/2004 | US20040259122 Autocatalysis/yeast two-hybrid assay |
12/23/2004 | US20040259113 by determining the presence of kallikrein protein, hK2 polypeptide of hK2 RNA in a physiological sample |